Novartis v Maphil (20229/2014) [2015] ZASCA 111; 2016 (1) SA 518 (SCA); [2015] 4 All SA 417 (SCA) (3 September 2015)

Novartis v Maphil (20229/2014) [2015] ZASCA 111; 2016 (1) SA 518 (SCA); [2015] 4 All SA 417 (SCA) (3 September 2015)

The Supreme Court of Appeal found that a binding contract was concluded between Novartis and Maphil (formerly Hiline) by 30 November 2004, comprising a written marketing agreement, oral undertakings, and email exchanges. The parties intended to be bound, performed their obligations, and finalized marketing activities as contemplated. The court rejected Novartis's argument that the contract was inchoate or unenforceable, holding that the absence of perfect clarity or formality did not negate contractual force. The representatives of Novartis had actual authority to bind the company, and the contract was repudiated by Novartis. Accordingly, Novartis was liable for damages as awarded by the...

Citation
[2015] ZASCA 111
Parties
Appellant: Novartis South Africa (Pty) Ltd; Respondent: Maphil Trading (Pty) Ltd
Court
Supreme Court of Appeal
Jurisdiction
South Africa
Judgment Date
3 September 2015
Case Number
20229/2014
Procedural Posture
Civil Appeal / Appeal From Gauteng Local Division of the High Court, Johannesburg
Outcome
Appeal dismissed with costs, including costs of two counsel where so employed.
Judges
Lewis, Majiedt, Pillay, Zondi, Mathopo
Legal Topics
Contractual Authority, Repudiation, Enforceability of Partly Written Partly Oral Contracts, Contractual Interpretation, Damages for Breach of Contract
Commercial and Corporate Civil Procedure Contractual Authority Repudiation Enforceability of Partly Written Partly Oral Contracts Contractual Interpretation Damages for Breach of Contract

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 10 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Novartis South Africa (Pty) Ltd

Appellant

Maphil Trading (Pty) Ltd

Respondent

Procedural Posture

Civil Appeal / Appeal From Gauteng Local Division of the High Court, Johannesburg

Legal Issues

  1. 1 Whether a binding contract was concluded between Novartis and Maphil (formerly Hiline).
  2. 2 Whether the contract, comprising written, oral, and email components, was enforceable.
  3. 3 Whether Novartis's representatives had actual or ostensible authority to bind Novartis.

Ratio Decidendi

The Supreme Court of Appeal found that a binding contract was concluded between Novartis and Maphil (formerly Hiline) by 30 November 2004, comprising a written marketing agreement, oral undertakings, and email exchanges. The parties intended to be bound, performed their obligations, and finalized marketing activities as contemplated. The court rejected Novartis's argument that the contract was inchoate or unenforceable, holding that the absence of perfect clarity or formality did not negate contractual force. The representatives of Novartis had actual authority to bind the company, and the contract was repudiated by Novartis. Accordingly, Novartis was liable for damages as awarded by the...

Court Disposition

Appeal dismissed with costs, including costs of two counsel where so employed.

Orders

  • The appeal is dismissed with costs, including the costs of two counsel where so employed.
  • Novartis is ordered to pay damages in the sum of R3,418,000 plus interest and costs of suit.